Better Choice CO INC
Market Movers (8-K)
SRX Global Inc. filed an amendment to its Form 8-K to correct a typographical error regarding the Chief Executive Officer's identification, clarifying Carolina Martinez as Chief Financial Officer.
Capital raise
SRX Global Inc. announced the successful completion of an additional closing for its private placement, raising approximately $3.47 million in cash.
Capital raise
SRX Global Inc. announced a Limited Waiver and Consent Agreement with Required Holders, allowing for a one-time cash dividend and a significant stock repurchase plan.
SRX Global Inc. announced it has regained full compliance with all NYSE American continued listing standards, resolving deficiencies previously noted.
SRX Global Inc. announced paper-traded EMJX returns of 26% from February 11, 2026, to July 10, 2026, significantly outperforming Bitcoin's -4.2% return over the same period.
SRX Global schedules a virtual fireside chat for July 14, 2026, to discuss recent developments, including the EMJX acquisition, and announces a share repurchase program and a cash dividend.
Quarterly Earnings (10-Q)
SRx Health Solutions reports Q1 2026 results, focusing on its Halo pet health business after discontinuing Canadian healthcare operations, while securing significant new financing.
Capital raise
Worse than expected
SRx Health Solutions Inc. reported a significant increase in net loss and a 65% drop in net sales for the nine months ended June 30, 2025, with its Canadian subsidiary filing for creditor protection post-period end.
Delay expected
Worse than expected
Capital raise
SRx Health Solutions Inc. reports a net sales decrease of 9% for Q1 2025, alongside a business combination and strategic shifts in sales channels.
Worse than expected
Better Choice Company Inc. reports a net income of $1.5 million for Q3 2024, a significant turnaround from a net loss in the same period last year, despite a decrease in net sales.
Better than expected
Capital raise
Better Choice Co Inc. reported a net income of $2.654 million for the second quarter of 2024, a significant turnaround from a net loss of $2.964 million in the same period last year, despite a decrease in net sales.
Better than expected
Capital raise
Better Choice Company Inc. experienced a 14% decrease in net sales in Q1 2024 compared to Q1 2023, alongside a net loss of $2.83 million, highlighting ongoing financial challenges.
Worse than expected
Capital raise
Annual Reports (10-K)
SRx Health Solutions Inc. has completed a reverse merger, discontinuing its Canadian healthcare operations to focus solely on its Halo pet health and wellness business, despite reporting significant losses.
Worse than expected
Capital raise
Delay expected
Better Choice Company Inc. reports a net sales decrease of 9% for fiscal year 2024, alongside a strategic shift towards digital channels and a pending merger with SRx Health Solutions.
Capital raise
Better than expected
Better Choice Company Inc. reported a decrease in net sales for 2023, impacted by supply chain issues and strategic channel exits, while also highlighting a focus on profitability and digital-first strategy.
Worse than expected
Delay expected
Capital raise
Insider Trading (Form 4)
Kent Douglas Cunningham, CEO of SRx Health Solutions, reports significant transactions involving common stock and Series B Preferred Stock.
SRx Health Solutions, Inc. reports a significant share acquisition by Director Simon Alexander Malcolm Conway.
SRx Health Solutions Director David Allan White reported multiple acquisitions of common stock and warrants, significantly increasing his beneficial ownership in the company.
Director Lionel F. Conacher of Better Choice Co Inc. has reported multiple transactions involving the company's common stock and stock options.
Director Lionel F. Conacher of Better Choice Co Inc. reports multiple transactions involving the company's common stock and stock options.
Proxy Statements (Def-14A)
SRx Health Solutions, Inc. has secured majority shareholder approval for significant capital raises, an increase in authorized shares, a reduction in shareholder meeting quorum, and an additional reverse stock split.
Delay expected
Capital raise
SRx Health Solutions, Inc. announces a board-approved reverse stock split ranging from 15-to-1 to 60-to-1 to maintain NYSE American listing and enhance capital flexibility.
Capital raise
Better Choice Company Inc. supplements its proxy statement with details on a potential acquisition of Choice Specialty Pharmacy Group and an SRx debt conversion, while also extending the outside date for its arrangement agreement.
Delay expected
Better Choice Company Inc. will acquire SRx Health Solutions Inc. in an all-stock transaction, pending shareholder and regulatory approvals.
Delay expected
Worse than expected
Better Choice Company Inc. will hold its annual meeting of stockholders on December 18, 2024, to vote on the election of directors, executive compensation, the appointment of an independent registered public accountant, and other business matters.
Better Choice Company is implementing a reverse stock split, with a ratio between 1-for-25 and 1-for-45, to meet NYSE American listing requirements and enhance the appeal of its common stock.
Better than expected
New Public Companies (S-1)
SRx Health Solutions, Inc. is undergoing a significant business transformation, divesting its Canadian healthcare operations to focus on its Halo pet wellness brand and a proposed acquisition in AI and crypto technology, while facing substantial financial challenges and potential dilution.
Delay expected
Worse than expected
Capital raise
SRx Health Solutions, Inc. is undergoing a significant transformation, divesting its Canadian healthcare operations to focus on its Halo pet health and wellness business, while securing substantial financing through an Equity Line of Credit.
Delay expected
Worse than expected
Capital raise
SRx Health Solutions, Inc. reports substantial doubt about its ability to continue as a going concern, driven by significant net losses, negative operating cash flows, and Canadian subsidiary CCAA proceedings.
Delay expected
Worse than expected
Capital raise
SRx Health Solutions, Inc. is grappling with significant financial losses and a going concern warning, as its Canadian subsidiary enters creditor protection and the company registers 82 million shares for resale by Keystone Capital Partners.
Worse than expected
Capital raise
Delay expected
Better Choice Company aims to raise capital by offering 1,640,000 shares of common stock and pre-funded warrants.
Capital raise
Better Choice Company Inc. plans to raise capital through a public offering of 1,640,000 shares of common stock and pre-funded warrants.
Capital raise
Schedule 13G - Passive Investments
SCHEDULE: SRX Global Inc. Ownership Update
SRX Global Inc. reports a Schedule 13G filing indicating zero beneficial ownership for Les Filles, LLC, Michael A. Parker, and Tungsten III LLC as of July 8, 2026, following a recent merger and stock split.
SCHEDULE: SRX Global: Major Stakeholder Disclosure
Les Filles, LLC, Tungsten III LLC, and Michael A. Parker have disclosed a 6.2% beneficial ownership stake in SRX Global Inc.
Kevin Egan has reported a 5.0% beneficial ownership stake in SRx Health Solutions, Inc., holding 14,031,500 shares of common stock.
Altium Capital Management LLC and its affiliated entities have filed an amended Schedule 13G, disclosing a passive beneficial ownership of 0.27% in SRx Health Solutions, Inc.
SCHEDULE 13G/A: Altium Entities Disclose 6.1% Stake in Better Choice Co Inc. via Warrants and Common Stock
Altium Capital Management LLC and its affiliated entities have disclosed a 6.1% beneficial ownership stake in Better Choice Co Inc., primarily through pre-funded warrants and common stock, as of December 31, 2024.
Capital raise